Skip to main content

Table 1 General characteristics of the study population

From: Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine

  Total
n = 575
Females
n = 272
Males
n = 303
P
Age (years) 36 ± 12 36 ± 13 35.6 ± 12.1 0.789
Diabetes duration (years) 19 ± 11 19.1 ± 10.5 18.8 ± 10.9 0.739
Early onset T1D (1–10 years of age) (%) 31.3 32.4 30.4 0.653
Age of T1D onset (years) 16.8 ± 10.8 16.7 ± 11.1 17 ± 10.4 0.712
Waist circumference (cm) 86.0 ± 11.8 82.4 ± 11.3 89.3 ± 11.2 < 0.0001
BMI (kg/m2) 25.1 ± 3.6 24.7 ± 3.8 25.4 ± 3.3 0.018
HbA1c (%) 7.7 ± 1.2 7.9 ± 1.2 7.7 ± 1.22 0.064
SBP (mmHg) 121 ± 16 118 ± 17 123 ± 14 < 0.0001
DBP (mmHg) 75 ± 10 73 ± 11 76 ± 9 0.001
Total cholesterol (mg/dl) 178 ± 34 181.5 ± 35.7 175.6 ± 33 0.040
LDL-cholesterol (mg/dl) 101 ± 29 100 ± 28.1 101.5 ± 29.5 0.468
HDL-cholesterol (mg/dl) 62 ± 16 68 ± 17.3 56.9 ± 13.9 < 0.0001
Triglycerides (mg/dl) 79 ± 52 71.2 ± 36.7 86.5 ± 62.3 < 0.0001
eGFR (CKD-EPI) (ml/min/1.73 m2) 101.8 ± 18 100.7 ± 18.6 102.8 ± 17.5 0.168
Other autoimmune diseases (%) 35 44.9 25.4 < 0.0001
CSII (%) 32.5 38.7 26.9 0.003
Microvascular complications (%) 27.7 26.8 28.4 0.679
Nephropathy (%) 9.7 9.4 10.1 0.778
Retinopathy (%) 18.8 15.2 22.1 0.038
Neuropathy (%) 10.4 10.9 10.07 0.727
Previous CVD (%) 3.8 3.3 4.3 0.540
Hypertension (%) 29.4 25.4 33 0.050
Hypercholesterolemia (%) 53 49.6 56.1 0.132
  1. Data are expressed as Mean ± standard deviation or as a percentage
  2. SBP systolic blood pressure, DBP diastolic blood pressure, CVD Cardiovascular disease (Ischemic heart disease, stroke, peripheral arteriopathy), eGFR estimated glomerular filtration rate, CSII continuous subcutaneous insulin infusion